Application Sponsors
ANDA 061605 | BRISTOL MYERS SQUIBB | |
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Application Products
001 | TABLET;ORAL | EQ 250MG BASE | 0 | ETHRIL 250 | ERYTHROMYCIN STEARATE |
002 | TABLET;ORAL | EQ 500MG BASE | 0 | ETHRIL 500 | ERYTHROMYCIN STEARATE |
CDER Filings
BRISTOL MYERS SQUIBB
cder:Array
(
[0] => Array
(
[ApplNo] => 61605
[companyName] => BRISTOL MYERS SQUIBB
[docInserts] => ["",""]
[products] => [{"drugName":"ETHRIL 250","activeIngredients":"ERYTHROMYCIN STEARATE","strength":"EQ 250MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ETHRIL 500","activeIngredients":"ERYTHROMYCIN STEARATE","strength":"EQ 500MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ETHRIL 250","submission":"ERYTHROMYCIN STEARATE","actionType":"EQ 250MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"ETHRIL 500","submission":"ERYTHROMYCIN STEARATE","actionType":"EQ 500MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)